Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-055069

Director sold 12,000 shares at an average $52.84 ($634,097)

  • Director acquired 12,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

GRIFFIN MICHELLE RENEE · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2020-10-14 Exercise or conversion : show line 1 in the form +12,000 $7.80 $93,600 12,000 D
2020-10-14 Sale : show line 2 in the form −4,649 $52.48 $243,980 7,351 D
2020-10-14 Sale : show line 3 in the form −7,351 $53.07 $390,118 0 D
Open-market sales · 12,000 sh · avg $52.84 · $634,097

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-10-14 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −12,000 113,000 D
Loading xslF345X03/doc4.xml…